open access

Vol 21, No 2 (2016)
Special Issue Papers
Published online: 2016-03-01
Submitted: 2014-02-27
Get Citation

Radiotherapy dose enhancement using BNCT in conventional LINACs high-energy treatment: Simulation and experiment

Katia Alikaniotis, Oscar Borla, Valeria Monti, Gianna Vivaldo, Alba Zanini, Gianrossano Giannini
DOI: 10.1016/j.rpor.2015.07.003
·
Rep Pract Oncol Radiother 2016;21(2):117-122.

open access

Vol 21, No 2 (2016)
Special Issue Papers
Published online: 2016-03-01
Submitted: 2014-02-27

Abstract

Aim

To employ the thermal neutron background that affects the patient during a traditional high-energy radiotherapy treatment for BNCT (Boron Neutron Capture Therapy) in order to enhance radiotherapy effectiveness.

Background

Conventional high-energy (15–25[[ce:hsp sp="0.25"/]]MV) linear accelerators (LINACs) for radiotherapy produce fast secondary neutrons in the gantry with a mean energy of about 1[[ce:hsp sp="0.25"/]]MeV due to (γ, n) reaction. This neutron flux, isotropically distributed, is considered as an unavoidable undesired dose during the treatment. Considering the moderating effect of human body, a thermal neutron fluence is localized in the tumour area: this neutron background could be employed for BNCT by previously administering 10B-Phenyl-Alanine (10BPA) to the patient.

Materials and methods

Monte Carlo simulations (MCNP4B-GN code) were performed to estimate the total amount of neutrons outside and inside human body during a traditional X-ray radiotherapy treatment.

Moreover, a simplified tissue equivalent anthropomorphic phantom was used together with bubble detectors for thermal and fast neutron to evaluate the moderation effect of human body.

Results

Simulation and experimental results confirm the thermal neutron background during radiotherapy of 1.55E07[[ce:hsp sp="0.25"/]]cm−2[[ce:hsp sp="0.25"/]]Gy−1.

The BNCT equivalent dose delivered at 4[[ce:hsp sp="0.25"/]]cm depth in phantom is 1.5[[ce:hsp sp="0.25"/]]mGy-eq/Gy, that is about 3[[ce:hsp sp="0.25"/]]Gy-eq (4% of X-rays dose) for a 70[[ce:hsp sp="0.25"/]]Gy IMRT treatment.

Conclusions

The thermal neutron component during a traditional high-energy radiotherapy treatment could produce a localized BNCT effect, with a localized therapeutic dose enhancement, corresponding to 4% or more of photon dose, following tumour characteristics. This BNCT additional dose could thus improve radiotherapy, acting as a localized radio-sensitizer.

Abstract

Aim

To employ the thermal neutron background that affects the patient during a traditional high-energy radiotherapy treatment for BNCT (Boron Neutron Capture Therapy) in order to enhance radiotherapy effectiveness.

Background

Conventional high-energy (15–25[[ce:hsp sp="0.25"/]]MV) linear accelerators (LINACs) for radiotherapy produce fast secondary neutrons in the gantry with a mean energy of about 1[[ce:hsp sp="0.25"/]]MeV due to (γ, n) reaction. This neutron flux, isotropically distributed, is considered as an unavoidable undesired dose during the treatment. Considering the moderating effect of human body, a thermal neutron fluence is localized in the tumour area: this neutron background could be employed for BNCT by previously administering 10B-Phenyl-Alanine (10BPA) to the patient.

Materials and methods

Monte Carlo simulations (MCNP4B-GN code) were performed to estimate the total amount of neutrons outside and inside human body during a traditional X-ray radiotherapy treatment.

Moreover, a simplified tissue equivalent anthropomorphic phantom was used together with bubble detectors for thermal and fast neutron to evaluate the moderation effect of human body.

Results

Simulation and experimental results confirm the thermal neutron background during radiotherapy of 1.55E07[[ce:hsp sp="0.25"/]]cm−2[[ce:hsp sp="0.25"/]]Gy−1.

The BNCT equivalent dose delivered at 4[[ce:hsp sp="0.25"/]]cm depth in phantom is 1.5[[ce:hsp sp="0.25"/]]mGy-eq/Gy, that is about 3[[ce:hsp sp="0.25"/]]Gy-eq (4% of X-rays dose) for a 70[[ce:hsp sp="0.25"/]]Gy IMRT treatment.

Conclusions

The thermal neutron component during a traditional high-energy radiotherapy treatment could produce a localized BNCT effect, with a localized therapeutic dose enhancement, corresponding to 4% or more of photon dose, following tumour characteristics. This BNCT additional dose could thus improve radiotherapy, acting as a localized radio-sensitizer.

Get Citation

Keywords

BNCT; e-LINAC; Photo-production; Neutron

About this article
Title

Radiotherapy dose enhancement using BNCT in conventional LINACs high-energy treatment: Simulation and experiment

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 21, No 2 (2016)

Pages

117-122

Published online

2016-03-01

DOI

10.1016/j.rpor.2015.07.003

Bibliographic record

Rep Pract Oncol Radiother 2016;21(2):117-122.

Keywords

BNCT
e-LINAC
Photo-production
Neutron

Authors

Katia Alikaniotis
Oscar Borla
Valeria Monti
Gianna Vivaldo
Alba Zanini
Gianrossano Giannini

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl